hypoxanthine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyett, J; Dervieux, T; Evans, WE; Hancock, ML; Pui, CH; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
Devraj, R; Gangjee, A; Kisliuk, RL; McGuire, JJ | 1 |
Adachi, S; Akiyama, Y; Hashimoto, H; Kasai, Y; Kubota, M; Mikawa, H; Sano, H; Shimizu, T | 1 |
Conroy, MC; Dong, MK; Gilbertsen, RB; Kossarek, LM; Kostlan, CR; Sircar, JC | 1 |
1 trial(s) available for hypoxanthine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Bone Marrow Cells; Child; Chromatography, High Pressure Liquid; Humans; Hypoxanthine; Injections, Intravenous; Leukocyte Count; Mercaptopurine; Methotrexate; Nucleosides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Xanthines | 2003 |
3 other study(ies) available for hypoxanthine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Topics: Antineoplastic Agents; Cell Division; Folic Acid; Folic Acid Antagonists; Humans; Hypoxanthine; Hypoxanthines; Kinetics; Lacticaseibacillus casei; Leucovorin; Methotrexate; Molecular Structure; Peptide Synthases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recombinant Proteins; Structure-Activity Relationship; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured | 1995 |
Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute leukemia or non-Hodgkin lymphoma in childhood.
Topics: Adolescent; Child; Humans; Hypoxanthine; Hypoxanthines; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uridine | 1992 |
Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972.
Topics: Adenine; Cell Division; Deoxycytidine; Deoxyguanine Nucleotides; DNA Replication; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Kinetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine-Nucleoside Phosphorylase; Pyrimidines; T-Lymphocytes; Thiophenes | 1991 |